FDAÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳָµ¼Ô­Ôò(¶þ)_ͼ(¾«) ÏÂÔØ±¾ÎÄ

ÄÚÈÝ·¢²¼¸üÐÂʱ¼ä : 2025/10/7 6:20:35ÐÇÆÚÒ» ÏÂÃæÊÇÎÄÕµÄÈ«²¿ÄÚÈÝÇëÈÏÕæÔĶÁ¡£

ÄúÏÖÔÚµÄλÖ㺵ç×Ó¿¯Îï >> µç×Ó¿¯ÎïÁбí >> µç×Ó¿¯ÎïÏêϸ

·¢²¼ÈÕÆÚ 20110531

À¸Ä¿ »¯Ò©Ò©ÎïÆÀ¼Û>>»¯Ò©ÖÊÁ¿¿ØÖÆ

±êÌâ FDA ÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳָµ¼Ô­Ôò£¨¶þ£© ×÷Õß ¸ßÑî

²¿ÃÅ »¯Ò©Ò©Ñ§¶þ²¿ ÕýÎÄÄÚÈÝ °´Ó

ÃÀ¹úFDA ÓÚ1999Äê5Ô·¢²¼ÁËÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳָ µ¼Ô­Ôò£¨Container Closure Systems for Packaging Human Drugs and

Biologics £©£¬¼Ì¶øÓÚ3 ÄêºóÔٴη¢²¼ÁËÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳָµ¼Ô­Ôò--ÎÊÓë´ð£¨Container Closure Systems for Packaging Human Drugs and Biologics--Questions and Answers£©£¬¸ÃÖ¸µ¼Ô­Ôò´ú±íÁËFDA ¹ØÓÚÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳµÄÏÖÐй۵㣬¶ÔÓÚÎÒ¹úÒ©Æ·×¢²áÉêÇëÕߺÍÒ©Æ·¼à¹Üµ±¾Ö¶¼¾ßÓÐºÜ¸ßµÄ½è¼øÒâÒå¡£EMEA Ö±½Ó½Ó´¥ËÜÁϰü×°²ÄÁÏÖ¸µ¼Ô­ÔòµÄÖÐÎİæÒѾ­ÓÚ2011Äê4ÔÂÔÚÒ©ÉóÖÐÐÄÍøÕ¾ÉÏÒÔµç×Ó¿¯Îï·¢±í¡£´Ë´Î½«FDA µÄÏà¹Ø

Ö¸µ¼Ô­Ôò·­Òë³ÉÖÐÎÄ£¬¹©Òµ½ç²Î¿¼Ñо¿¡£

±¾ÎÄÔÚ·­Òë¹ý³ÌÖеõ½Á˰ÙÌØ£¨Öйú£©Í¶×ÊÓÐÏÞ¹«Ë¾µÄ½ðÌìÃ÷ŮʿºÍ¹¨Ã÷Ìβ©Ê¿µÄ´óÁ¦Ö§³Ö£¬Ôڴ˱íʾ³ÏֿлÒâ¡£¾¡¹ÜÒë¸å¾­¹ý±ÊÕßÈÏÕæÐ£ºË£¬µ«ÊÇÓÉÓÚË®

ƽÓÐÏÞ£¬ÎÄÖдíÎóÔÙËùÄÑÃ⣬¿ÒÇëÅúÆÀÖ¸Õý¡£

ÏÞÓÚµç×Ó¿¯ÎïµÄƪ·ù£¬½«¸ÃÖ¸µ¼Ô­Ôò½«·ÖΪËÄÆªÁ¬Ðø¿¯³ö£¬Ç°ÈýƪΪÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü×°ÓÃÈÝÆ÷ÃÜ·âϵͳָµ¼Ô­Ôò£¬×îºóһƪΪÈËÓÃÒ©Æ·ºÍÉúÎïÖÆÆ·°ü

×°ÓÃÈÝÆ÷ÃÜ·âϵͳָµ¼Ô­Ôò--ÎÊÓë´ð£¬±¾ÎÄΪµÚ¶þƪ¡£ C £®ÎªÖ§³ÖÈκÎÒ©Æ·µÄ³õ´ÎÉêÇë¶øÓ¦Ìá½»µÄ×ÊÁÏ15

ÉêÇë×ÊÁÏ£¨NDA ¡¢ANDA »òBLA £©CMC ²¿·ÖÖÐÓ¦µ±ÌṩµÄÆäËû×ÊÁÏÏà¹ØµÄ ÐÅÏ¢ºÍÌÖÂÛÇë¼û¸½Â¼E ÁгöµÄÖ¸µ¼Ô­Ôò¡£ 1£®ËµÃ÷

É걨×ÊÁϵÄCMC ²¿·ÖÓ¦µ±ÌṩÕû¸öÈÝÆ÷ÃÜ·âϵͳµÄ×ÜÌå˵Ã÷¡£´ËÍ⣬ÉêÇë ÈË»¹Ó¦Ìṩ°üװϵͳÿ¸ö×é¼þµÄÒÔÏÂÐÅÏ¢£º

a £®²úÆ·Ãû³Æ¡¢²úÆ·´úÂ루Èç¹ûÓеϰ£©¡¢Éú²ú³§Ãû³Æ¼°µØÖ·¡¢°ü×°×é¼þÎïÀíÌØ

Õ÷£¨ÀýÈçÐͺš¢´óС¡¢ÐÎ×´ºÍÑÕÉ«£©¡£

b £®×é³É²ÄÁÏ£¨¼´ËÜÁÏ¡¢Ö½¡¢½ðÊô¡¢²£Á§¡¢ÈËÔìÏ𽺡¢Í¿ÁÏ¡¢Õ³ºÏ¼ÁºÍÆäËû´ËÀà²ÄÁÏ£©µÄÌØÕ÷ÐÔÐÅÏ¢£¬¼´¿ÉÒÔͨ¹ýÌØ¶¨µÄÌØÕ÷ÐÔÐÅÏ¢£¨´úÂëÃû³ÆºÍ/»ò´úÂë±àºÅ£©ºÍÀ´Ô´£¨Éú²ú³§Ãû³Æ£©½øÐвÄÁϵÄʶ±ð16¡£»¹Ó¦Ìṩ¿ÉÌæ´ú×é³É²ÄÁϵÄÐÅÏ¢¡£Ïû·Ñºó»ØÊÕµÄËÜÁÏ£¬²»ÄÜÓÃÓÚÖ÷°ü×°×é¼þµÄÉú²úÖУ¬Èç¹ûÓÃÓڴμ¶°ü×°»òÏà¹ØÅä¼þ£¬

ÔòÓ¦Ìṩ¸Ã²ÄÁÏ¿ÉÓÃÓÚÔ¤ÆÚÓÃ;µÄ°²È«ÐÔºÍÏàÈÝÐÔÒÀ¾Ý¡£

c £®ÉêÇëÈËÓ¦µ±ËµÃ÷¶Ô°ü×°×é¼þ½øÐеÄÈκμӹ¤»ò´¦Àí¹ý³Ì£¨ÀýÈçÏ´µÓ¡¢¸²²ã¡¢

Ãð¾ú»òÈ¥ÈÈÔ­£©17¡£

2£®¹ØÓÚÊÊÓÃÐÔµÄ×ÊÁÏ

a £®ÎªÁËÈ·Ö¤°²È«ÐԺͱ£Ö¤ÖÊÁ¿Ò»ÖÂÐÔ£¬Ó¦ÌṩÉú²ú°ü×°×é¼þµÄÿÖÖ²ÄÁÏÍêÕûµÄ

»¯Ñ§×é³É¡£

b £®Ó¦ÌṩÊʵ±µÄºÏ¸ñÐÔÈ·ÈÏÊÔÑéºÍ¼ø±ðÊÔÑéµÄ½á¹û¡£Ó¦µ±ÌṩÊÔÑé¡¢·½·¨¡¢½Ó

Êܱê×¼¡¢±ê׼ƷºÍ³ä·ÖµÄÑéÖ¤ÐÅÏ¢¡£

¹ØÓÚ±£»¤ÐÔ£¬Ò»°ãÈÏΪUSP ¹ØÓÚ¹â͸¹ý¡¢Í¸ÊªÐÔ¡¢Î¢ÉúÎïÏ޶ȺÍÎÞ¾úµÄ¼ì²é£¨Çë¼û¸½Â¼A £©¾Í×ã¹»ÁË¡£USP ¹æ¶¨µÄÆäËûÊÔÑ飨ÀýÈçÍ¸ÆøÐÔ¡¢ÈܼÁй©£¬ÈÝ

Æ÷ÍêÕûÐÔ£©Ò²¿ÉÄÜÒ²ÊDZØÒªµÄ¡£

¹ØÓÚ°²È«ÐÔºÍÏàÈÝÐÔ£¬¶ÔÓÚ¿ÉÄÜÓë°ü×°×é¼þ·¢ÉúÏ໥×÷Óò¢°ÑÌáÈ¡Îï´øÈ뻼ÕßÌåÄÚµÄÖÆ¼Á£¬Ó¦µ±ÌṩÌáÈ¡ÎïÑо¿/¶¾ÀíѧÆÀ¹ÀµÄ±¨¸æ£¬ÒÔ˵Ã÷Æä°²È«ÐÔºÍÏàÈÝÐÔ£¨¼û±í1£©¡£¶ÔÓÚ²»Ì«¿ÉÄÜ·¢ÉúÏ໥×÷ÓõÄÖÆ¼Á£¬¿ÉÒÔʹÓÃÆäËûÊÔÑ飨ÀýÈçUSP ÉúÎï·´Ó¦ÐÔÊÔÑ飩»òÎÄÏ×£¨ÀýÈçºÏÀíÒýÓÃ21 CFR 174 - 786 Ïîϼä½ÓʳƷÌí¼Ó¼ÁÌõÀý£©À´ËµÃ÷°²È«ÐÔºÍÏàÈÝÐÔÎÊÌ⣨¼û±í2£©¡£ÀýÈ磬ºÏÀíÒýÓüä½ÓʳƷÌí¼Ó

¼ÁÌõÀý¶ÔÓÚ¹ÌÌå¿Ú·þÖÆ¼ÁÒ»°ã¾Í×ã¹»ÁË¡£

¶ÔÓÚÐÔÄÜ£¬Èç¹û²âÊԺͽÓÊܱê×¼ÓëÆäÔ¤ÆÚÄ¿µÄÏàÆ¥Å䣬ÔòUSP ºÍ·ÇUSP µÄ ¹¦ÄÜÐÔ¼ì²é½á¹û×ãÒÔ˵Ã÷¡£

ÓÃUPS ¹æ¶¨µÄ²âÊÔ·½·¨£¬À´½¨Á¢×é³É²ÄÁÏ»ò°ü×°×é¼þµÄÌØÐÔ¼ì²éºÍÌØÕ÷¼ø ±ð·½·¨£¬Í¨³£±»ÈÏΪÊdzä·ÖµÄ¡£